when should take l-carnitine | Linus Pauling Institute How Long Should You Take
Description
A phase 2 study of SRT501 (resveratrol) with bortezomib for patients with relapsed and or refractory multiple myeloma
C.ZhengL.ZhuR.WangB
(1270) Shimazu, T
Consumer Advisory: Be wary of package deals that pressure you into a high volume of treatments upfront
